These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

185 related articles for article (PubMed ID: 22446381)

  • 21. FlexE: efficient molecular docking considering protein structure variations.
    Claussen H; Buning C; Rarey M; Lengauer T
    J Mol Biol; 2001 Apr; 308(2):377-95. PubMed ID: 11327774
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Conformational energy range of ligands in protein crystal structures: The difficult quest for accurate understanding.
    Peach ML; Cachau RE; Nicklaus MC
    J Mol Recognit; 2017 Aug; 30(8):. PubMed ID: 28233410
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Flexible ligand docking using conformational ensembles.
    Lorber DM; Shoichet BK
    Protein Sci; 1998 Apr; 7(4):938-50. PubMed ID: 9568900
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Structure-Based Analysis of Cryptic-Site Opening.
    Sun Z; Wakefield AE; Kolossvary I; Beglov D; Vajda S
    Structure; 2020 Feb; 28(2):223-235.e2. PubMed ID: 31810712
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Models of protein-ligand crystal structures: trust, but verify.
    Deller MC; Rupp B
    J Comput Aided Mol Des; 2015 Sep; 29(9):817-36. PubMed ID: 25665575
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Towards in silico lead optimization: scores from ensembles of protein/ligand conformations reliably correlate with biological activity.
    Popov VM; Yee WA; Anderson AC
    Proteins; 2007 Feb; 66(2):375-87. PubMed ID: 17078091
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Predicting Ligand Binding Sites on Protein Surfaces by 3-Dimensional Probability Density Distributions of Interacting Atoms.
    Jian JW; Elumalai P; Pitti T; Wu CY; Tsai KC; Chang JY; Peng HP; Yang AS
    PLoS One; 2016; 11(8):e0160315. PubMed ID: 27513851
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Automating crystallographic structure solution and refinement of protein-ligand complexes.
    Echols N; Moriarty NW; Klei HE; Afonine PV; Bunkóczi G; Headd JJ; McCoy AJ; Oeffner RD; Read RJ; Terwilliger TC; Adams PD
    Acta Crystallogr D Biol Crystallogr; 2014 Jan; 70(Pt 1):144-54. PubMed ID: 24419387
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Hydration properties of ligands and drugs in protein binding sites: tightly-bound, bridging water molecules and their effects and consequences on molecular design strategies.
    García-Sosa AT
    J Chem Inf Model; 2013 Jun; 53(6):1388-405. PubMed ID: 23662606
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Automated ligand fitting by core-fragment fitting and extension into density.
    Terwilliger TC; Klei H; Adams PD; Moriarty NW; Cohn JD
    Acta Crystallogr D Biol Crystallogr; 2006 Aug; 62(Pt 8):915-22. PubMed ID: 16855309
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Sequence assignment for low-resolution modelling of protein crystal structures.
    Chojnowski G; Pereira J; Lamzin VS
    Acta Crystallogr D Struct Biol; 2019 Aug; 75(Pt 8):753-763. PubMed ID: 31373574
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Comprehensive identification of "druggable" protein ligand binding sites.
    An J; Totrov M; Abagyan R
    Genome Inform; 2004; 15(2):31-41. PubMed ID: 15706489
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Prediction of models for ordered solvent in macromolecular structures by a classifier based upon resolution-independent projections of local feature data.
    Jones L; Tynes M; Smith P
    Acta Crystallogr D Struct Biol; 2019 Aug; 75(Pt 8):696-717. PubMed ID: 31373570
    [TBL] [Abstract][Full Text] [Related]  

  • 34. You are lost without a map: Navigating the sea of protein structures.
    Lamb AL; Kappock TJ; Silvaggi NR
    Biochim Biophys Acta; 2015 Apr; 1854(4):258-68. PubMed ID: 25554228
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Connectivity and binding-site recognition: applications relevant to drug design.
    Illingworth CJ; Scott PD; Parkes KE; Snell CR; Campbell MP; Reynolds CA
    J Comput Chem; 2010 Nov; 31(15):2677-88. PubMed ID: 20839295
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Automated protein-ligand crystallography for structure-based drug design.
    Mooij WT; Hartshorn MJ; Tickle IJ; Sharff AJ; Verdonk ML; Jhoti H
    ChemMedChem; 2006 Aug; 1(8):827-38. PubMed ID: 16902937
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Building a structured PDB: the RS-PDB database.
    Szabadka Z; Grolmusz V
    Conf Proc IEEE Eng Med Biol Soc; 2006; 2006():5755-8. PubMed ID: 17945915
    [TBL] [Abstract][Full Text] [Related]  

  • 38. '
    Chakraborti S; Hatti K; Srinivasan N
    Int J Mol Sci; 2021 Jun; 22(13):. PubMed ID: 34202053
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Automated prediction of ligand-binding sites in proteins.
    Harris R; Olson AJ; Goodsell DS
    Proteins; 2008 Mar; 70(4):1506-17. PubMed ID: 17910060
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Ligand placement based on prior structures: the guided ligand-replacement method.
    Klei HE; Moriarty NW; Echols N; Terwilliger TC; Baldwin ET; Pokross M; Posy S; Adams PD
    Acta Crystallogr D Biol Crystallogr; 2014 Jan; 70(Pt 1):134-43. PubMed ID: 24419386
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.